Role of polyanhydrides as localized drug carriers

被引:117
|
作者
Jain, JP
Modi, S
Domb, AJ
Kumar, N
机构
[1] Natl Inst Pharmaceut Educ & Res, Dept Pharmaceut, SAS Nagar 160062, Punjab, India
[2] Hebrew Univ Jerusalem, Dept Med Chem & Nat Prod, IL-91120 Jerusalem, Israel
关键词
biodegradable polymers; polyanhydrides; localized delivery; cancer; implants;
D O I
10.1016/j.jconrel.2004.12.021
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Many drugs that are administered in an unmodified form by conventional systemic routes fail to reach target organs in an effective concentration, or are not effective over a length of time due to a facile metabolism. Various types of targeting delivery systems and devices have been tried over a long period of time to overcome these problems. Targeted delivery or localized drug delivery offers an advantage of reduced body burden and systemic toxicity of the drugs, especially useful for highly toxic drugs like anticancer agents. Local drug delivery via polymer is a simple approach and hypothesized to avoid the above stated problems. Polyanhydrides are a unique class of polymer for drug delivery because some of them demonstrate a near zero order drug release and relatively rapid biodegradation in vivo. Further, the release rate of polyanhydride fabricated device can be altered over a thousand fold by simple changes in the polymer backbone. Hence, these are one of the best-suited polymers for drug delivery, with biodegradability and biocompatibility. The review focuses on the advantages of polyanhydride carriers in localized drug delivery along with their degradability behavior, toxicological profile and role in various disease conditions. (c) 2005 Elsevier B.V All rights reserved.
引用
收藏
页码:541 / 563
页数:23
相关论文
共 50 条
  • [41] ON TRAPPING OF FREE AND RELEASE OF LOCALIZED CARRIERS IN SOLIDS
    ANTONOVR.VV
    PHYSICA STATUS SOLIDI, 1968, 30 (01): : 341 - &
  • [42] BIOERODIBLE POLYANHYDRIDES FOR ANTIBIOTIC DRUG DELIVERY - INVIVO OSTEOMYELITIS TREATMENT IN A RAT MODEL SYSTEM
    LAURENCIN, CT
    GERHART, T
    WITSCHGER, P
    SATCHER, R
    DOMB, A
    ROSENBERG, AE
    HANFF, P
    EDSBERG, L
    HAYES, W
    LANGER, R
    JOURNAL OF ORTHOPAEDIC RESEARCH, 1993, 11 (02) : 256 - 262
  • [43] Intravitreal implants. Drug carriers and carriers of hope?
    Winterhalter, S.
    Ruokonen, P.
    van der Velden, K. H.
    Pleyer, U.
    Joussen, A. M.
    OPHTHALMOLOGE, 2011, 108 (03): : 222 - 229
  • [44] Driving forces for drug loading in drug carriers
    Li, Yang
    Yang, Li
    JOURNAL OF MICROENCAPSULATION, 2015, 32 (03) : 255 - 272
  • [45] IMPACT OF LIPOSOMAL DRUG CARRIERS ON DRUG PHARMACOKINETICS
    HUNT, CA
    MACGREGOR, RD
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1985, 74 (08) : 897 - 898
  • [46] POLYALKYLCYANOACRYLATES AS COLLOIDAL DRUG CARRIERS
    COUVREUR, P
    CRC CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 1988, 5 (01): : 1 - 20
  • [47] Carriers enhance drug delivery
    Houlton, S
    MANUFACTURING CHEMIST, 1999, 70 (06): : 25 - 26
  • [48] POLYSACCHARIDE NANOHYDROGELS AS DRUG CARRIERS
    Matricardi, P.
    Di Meo, C.
    Montanari, E.
    D'Arrigo, G.
    Manzi, G.
    Coviello, T.
    PROCEEDINGS OF THE 10TH INTERNATIONAL CONFERENCE ON POLYSACCHARIDES-GLYCOSCIENCE, 2014, : 119 - 120
  • [49] Micro and nanoparticles as drug carriers
    Leucuta, SE
    NBC RISKS: CURRENT CAPABILITIES AND FUTURE PERSPECTIVES FOR PROTECTION, 1999, 25 : 411 - 439
  • [50] Microbial Exopolysaccharides as Drug Carriers
    Tabernero, Antonio
    Cardea, Stefano
    POLYMERS, 2020, 12 (09)